2012–2013 | No of patients | TE (€) | %EPD |
---|---|---|---|
Glatiramer 18 mg | 146 | 1 050 550.00 | 17.1 |
Interferon beta-1a/1b | 393 | 2 484 601.00 | 40.4 |
Fingolimod | 81 | 862 391.00 | 14.0 |
Natalizumab | 115 | 1 741 563.00 | 28.4 |
Total | 735 | 6 139 105.00 | 100 |
2015–2016 | |||
Glatiramer 36 mg | 155 | 973 997.00 | 13.7 |
Interferon beta-1a/1b | 303 | 2 324 817.00 | 32.7 |
Fingolimod | 120 | 1 733 909.00 | 24.4 |
Natalizumab | 98 | 1 310 109.00 | 18.4 |
Teriflunomide | 27 | 193 762.00 | 2.7 |
Dimethyl fumarate | 55 | 374 887.00 | 5.3 |
Peginterferon beta-1a | 5 | 23 551.00 | 0.3 |
Alemtuzumab | 11 | 174 486.00 | 2.5 |
Total | 774 | 7 109 518.00 | 100.0 |